SARS-CoV-2-IN-13
SARS-CoV-2-IN-13 (compound 5) is a niclosamide analogue demonstrating enhanced metabolic stability in human plasma and liver S9 fractions, leading to improved oral bioavailability and half-life. This potent antiviral agent inhibits SARS-CoV-2 with an IC50 of 0.057 μM, supporting its investigation in both in vitro and in vivo antiviral research models.
Product Specifications
CAS Number
56961-10-5
Product Name Alternative
SARS-CoV-2, SARSCoV
Field of Research
Infectious Disease & Virology
Purity
98.15% (May vary between batches)
Solubility
DMSO:112.5 mg/mL (343.91 mM)
Smiles
Oc1ccc (Cl) cc1C (=O) Nc1ccc (c (Cl) c1) [N+] ([O-]) =O
Molecular Formula
C13H8Cl2N2O4
Molecular Weight
327.12
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP3-28023FR 0.1 mL
Human Monoclonal IL-9 Antibody (enokizumab) [DyLight 680]
Sign In for Pricing
View Details 
18588154 3x 1.0 µg DNA
DR1 CRISPR All-in-one AAV vector set (with saCas9)(Mouse)
Sign In for Pricing
View Details